Tirzepatide

Origen lists Tirzepatide 30 mg from ₱4,390 per vial. Bundle options and current prices are shown on this page. Shipping is ₱350 by LBC Express nationwide, or free on orders over ₱6,000. For laboratory research use only.

Origen accepts GCash and InstaPay bank transfer. Payment is verified before the order is packed. For laboratory research use only.

Eligible Metro Manila orders placed and paid before 12:00 PM on a business day can go out the same day by Lalamove or Angkas. Other orders ship by LBC Express and typically arrive 2-4 business days after dispatch in Luzon outside NCR, 3-5 in the Visayas and 4-6 in Mindanao. These are estimates, not promises. For laboratory research use only.

Same-day delivery in Metro Manila by Lalamove or Angkas costs ₱400 unless a qualifying offer applies, and it is free on orders over ₱6,000. Orders must be placed and paid before 12:00 PM on a business day, and eligibility depends on courier capacity, weather and the delivery address. For laboratory research use only.

If a parcel is damaged or incorrect, contact support within 24 hours of delivery with your order number and clear photos: WhatsApp +63 947 174 7187 or origencollectiveph@gmail.com. See the Claims & Replacement Policy and the Peptide Purity Guarantee for conditions. For laboratory research use only.

The Janoshik Analytical report (task #136367, unique key L4CE569LK1FD, tested 2026-04-09) is published on this page and in the certificate library. You can verify it on the laboratory's own verification page. The result applies to the referenced analysis, not every batch or vial. For laboratory research use only.

No. Origen supplies Tirzepatide for in-vitro laboratory research use only. For laboratory research use only.

Tirzepatide is a 39-amino-acid dual receptor agonist: it engages both the GIP receptor and the GLP-1 receptor from one molecule. Single-target compounds such as semaglutide act on the GLP-1 receptor only. In the head-to-head SURPASS-2 trial published in the New England Journal of Medicine, the dual-agonist design is what the researchers set out to isolate, which is why tirzepatide has become the reference compound in comparative incretin research.

( 1 ) GLP-1 receptor activity is studied for glucose-dependent insulin release, gastric emptying and appetite signalling. ( 2 ) GIP receptor activity is studied for insulin sensitivity, lipid handling and adipose-tissue energy metabolism. Tirzepatide is built on a GIP-based backbone with a C20 fatty-diacid chain that binds albumin, giving it a roughly five-day half-life.

The vial ships as a lyophilized (freeze-dried) powder, kept at 2–8°C and protected from light before reconstitution. You need bacteriostatic water plus standard supplies — syringes, alcohol prep pads and a mixing guide, all included in the Starter Kit and Research Bundle. Add 2–3 mL of bacteriostatic water, swirl gently instead of shaking, then refrigerate the reconstituted vial at 2–8°C.

Each vial contains 30 mg.

They differ in how many pathways they touch. Tirzepatide is dual-target (GIP + GLP-1) and carries the deepest published clinical dataset, including SURPASS and SURMOUNT. Retatrutide is triple-target (GIP + GLP-1 + glucagon); phase 3 results for TRIUMPH-1 and TRIUMPH-2 have been published, and it remains investigational. Researchers comparing established versus emerging incretin designs typically use tirzepatide as the benchmark arm.

Every Origen product has a published Certificate of Analysis, independently tested by Janoshik Analytical, showing purity results and a real, current test date. It is viewable on the Lab Results tab and on our Certificates page, and the task number and unique key are published on our Trust & Verification page so you can re-check the report at the laboratory yourself.

Same-day delivery within Metro Manila via Lalamove and Angkas. Nationwide express delivery via LBC Express, with free shipping on orders over ₱6,000. Support: WhatsApp +63 947 174 7187 or origencollectiveph@gmail.com.

Add 2–3 mL of bacteriostatic water to the 30 mg vial — 3 mL gives a 10 mg/mL working solution. Direct the stream against the glass wall, swirl gently rather than shaking, and store the reconstituted vial refrigerated at 2–8°C, protected from light.

Each vial contains 30 mg.

Tirzepatide is a dual agonist — it engages the GIP and GLP-1 receptors. Retatrutide adds a third target, the glucagon receptor. Tirzepatide has the far larger published clinical dataset of the two, which is why it is often the reference compound in comparative metabolic research.

Yes. This product's Certificate of Analysis is issued by Janoshik Analytical, an independent third-party laboratory. It is viewable under the Lab Results tab, and the report's task number and unique key are published on our Trust & Verification page so you can re-check it at janoshik.com/verification yourself.

Orders ship in plain outer packaging within 1–2 business days. Same-day delivery within Metro Manila via Lalamove and Angkas, nationwide express via LBC Express. Free shipping on orders over ₱6,000 within the Philippines.

No. All compounds sold are strictly for in-vitro laboratory research use only and are not for human or veterinary consumption.